Literature DB >> 32665373

COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy.

Stefania Bellino1,2, Ornella Punzo3,2, Maria Cristina Rota3, Martina Del Manso3, Alberto Mateo Urdiales3, Xanthi Andrianou3, Massimo Fabiani3, Stefano Boros3, Fenicia Vescio, Flavia Riccardo3, Antonino Bella3, Antonietta Filia3, Giovanni Rezza4, Alberto Villani5, Patrizio Pezzotti3.   

Abstract

OBJECTIVES: To describe the epidemiological and clinical characteristics of coronavirus disease (COVID-19) pediatric patients aged <18 years in Italy.
METHODS: Data from the national case-based surveillance system of confirmed COVID-19 infections until May 8, 2020, were analyzed. Demographic and clinical characteristics of subjects were summarized by age groups (0-1, 2-6, 7-12, 13-18 years), and risk factors for disease severity were evaluated by using a multilevel (clustered by region) multivariable logistic regression model. Furthermore, a comparison among children, adults, and elderly was performed.
RESULTS: Pediatric patients (3836) accounted for 1.8% of total infections (216 305); the median age was 11 years, 51.4% were male, 13.3% were hospitalized, and 5.4% presented underlying medical conditions. The disease was mild in 32.4% of cases and severe in 4.3%, particularly in children ≤6 years old (10.8%); among 511 hospitalized patients, 3.5% were admitted in ICU, and 4 deaths occurred. Lower risk of disease severity was associated with increasing age and calendar time, whereas a higher risk was associated with preexisting underlying medical conditions (odds ratio = 2.80, 95% confidence interval = 1.74-4.48). Hospitalization rate, admission in ICU, disease severity, and days from symptoms onset to recovery significantly increased with age among children, adults and elderly.
CONCLUSIONS: Data suggest that pediatric cases of COVID-19 are less severe than adults; however, age ≤1 year and the presence of underlying conditions represent severity risk factors. A better understanding of the infection in children may give important insights into disease pathogenesis, health care practices, and public health policies.
Copyright © 2020 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2020        PMID: 32665373     DOI: 10.1542/peds.2020-009399

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  52 in total

1.  Association between area-level material deprivation and incidence of hospitalization among children with SARS-CoV-2 in Montreal.

Authors:  Assil Abda; Francesca Del Giorgio; Lise Gauvin; Julie Autmizguine; Fatima Kakkar; Olivier Drouin
Journal:  Paediatr Child Health       Date:  2022-04-23       Impact factor: 2.600

2.  Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.

Authors:  Chiara Sacco; Martina Del Manso; Alberto Mateo-Urdiales; Maria Cristina Rota; Daniele Petrone; Flavia Riccardo; Antonino Bella; Andrea Siddu; Serena Battilomo; Valeria Proietti; Patrizia Popoli; Francesca Menniti Ippolito; Anna Teresa Palamara; Silvio Brusaferro; Giovanni Rezza; Patrizio Pezzotti; Massimo Fabiani
Journal:  Lancet       Date:  2022-07-01       Impact factor: 202.731

3.  Risk factors for COVID-19 hospitalisations and deaths in Mexican children and adolescents: retrospective cross-sectional study.

Authors:  Libny Martínez-Valdez; Vesta Richardson López Collada; Luis Enrique Castro-Ceronio; Ángela María Rodríguez Gutiérrez; Aurora Bautista-Márquez; Mauricio Hernandez-Avila
Journal:  BMJ Open       Date:  2022-06-17       Impact factor: 3.006

4.  Risk factors for disease severity and mortality of children with Covid-19: A study at a Vietnamese Children's hospital.

Authors:  Phung Nguyen The Nguyen; Tran Thanh Thuc; Nguyen Thanh Hung; Le Quoc Thinh; Ngo Ngoc Quang Minh; Dang Quoc Duy; Tran Minh Nhut; Nguyen Bich Y Linh; Tran Minh Tuan; Ngo Hoang Lam Giang; Vo Thi Minh Tuyen
Journal:  J Infect Chemother       Date:  2022-06-20       Impact factor: 2.065

5.  Factors Associated With COVID-19 Disease Severity in US Children and Adolescents.

Authors:  James W Antoon; Carlos G Grijalva; Cary Thurm; Troy Richardson; Alicen B Spaulding; Ronald J Teufel; Mario A Reyes; Samir S Shah; Julianne E Burns; Chén C Kenyon; Adam L Hersh; Derek J Williams
Journal:  J Hosp Med       Date:  2021-10       Impact factor: 2.899

6.  Children and the American Rescue Plan: countering COVID-19 vaccine hesitancy during a global pandemic.

Authors:  Shetal Shah
Journal:  Pediatr Res       Date:  2021-05-25       Impact factor: 3.756

7.  An epidemiological study of pediatric COVID-19 in the era of the variant of concern.

Authors:  Chanapai Chaiyakulsil; Paskorn Sritipsukho; Araya Satdhabudha; Pornumpa Bunjoungmanee; Auchara Tangsathapornpong; Phakatip Sinlapamongkolkul; Naiyana Sritipsukho
Journal:  PLoS One       Date:  2022-04-15       Impact factor: 3.240

8.  Prevalence of SARS-CoV-2 infection in Italian pediatric population: a regional seroepidemiological study.

Authors:  Manola Comar; Simone Benvenuto; Marzia Lazzerini; Giorgio Fedele; Egidio Barbi; Alessandro Amaddeo; Francesco Maria Risso; Tamara Strajn; Paola Di Rocco; Paola Stefanelli; Giovanni Rezza
Journal:  Ital J Pediatr       Date:  2021-06-05       Impact factor: 2.638

9.  SARS-CoV-2 Seroprevalence and Neutralizing Antibody Response after the First and Second COVID-19 Pandemic Wave in Croatia.

Authors:  Tatjana Vilibic-Cavlek; Vladimir Stevanovic; Maja Ilic; Ljubo Barbic; Krunoslav Capak; Irena Tabain; Jasna Lenicek Krleza; Thomas Ferenc; Zeljka Hruskar; Renata Zrinski Topic; Vanja Kaliterna; Arlen Antolovic-Pozgain; Jasmina Kucinar; Iva Koscak; Dijana Mayer; Mario Sviben; Ljiljana Antolasic; Ljiljana Milasincic; Lovro Bucic; Ivana Ferencak; Bernard Kaic
Journal:  Pathogens       Date:  2021-06-20

10.  COVID-19: Critical appraisal of the evidence.

Authors:  Paz González Rodríguez; Begoña Pérez-Moneo Agapito; María Salomé Albi Rodríguez; Pilar Aizpurua Galdeano; María Aparicio Rodrigo; María Mercedes Fernández Rodríguez; María Jesús Esparza Olcina; Carlos Ochoa Sangrador
Journal:  An Pediatr (Engl Ed)       Date:  2021-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.